Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: Results from Cancer and Leukemia Group B study 8461

Guido Marcucci, Krzysztof Mrózek, Amy S. Ruppert, Kellie J. Archer, Mark J. Pettenati, Nyla A. Heerema, Andrew J. Carroll, Prasad R K Koduru, Jonathan E. Kolitz, Lisa J. Sterling, Colin G. Edwards, John Anastasi, Richard A. Larson, Clara D. Bloomfield

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: Results from Cancer and Leukemia Group B study 8461'. Together they form a unique fingerprint.

Medicine & Life Sciences